RELEASE-HF研究:关于远程医疗在荷兰心力衰竭中的有效性的一项基于注册的观察性研究的协议
Jorna van Eijk1, Kim Luijken2, Tiny Jaarsma3
1General Practice and Nursing Science, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands j.vaneijk-4@umcutrecht.nl.
BMJ open
|January 4, 2024
概括
这项研究调查了心力衰竭 (HF) 患者远程医疗的成本效益. 它旨在识别产生最佳结果的患者子组和远程医疗组件,改进HF管理.
科学领域:
- 心脏病学 心脏病学
- 医疗保健服务研究 医疗服务研究
- 数字健康数字健康
背景情况:
- 分析表明,远程医疗对心力衰竭 (HF) 管理产生积极影响,减少住院治疗,死亡率和成本.
- 然而,由于患者群体的变化,远程医疗干预和比较器通常的护理质量,观察到的效果是异质的.
- 远程医疗在高频管理中的采用正在增加.
研究的目的:
- 确定特定的心力衰竭 (HF) 患者子组,其中远程医疗是最 (成本) 有效的.
- 确定哪些远程医疗组件在高频管理中最 (成本) 有效.
主要方法:
- 一项多中心,观察性,基于注册的队列研究 (RELEASE-HF),招募了6480名HF患者.
- 数据收集包括患者特征,治疗,诊断时的临床结果,6个月和12个月.
- 远程医疗的组成部分通过临床医生采访和电子健康记录进行评估;根据登记数据和采访计算的成本.
主要成果:
- 探索性的分层分析将评估远程医疗对没有计划外住院治疗的日子的影响的异质性.
- 单独的模型将评估单个远程医疗组件的影响.
- 将在预定义的患者特征和远程医疗干预措施中分析成本效益.
结论:
- 该研究将提供关于远程医疗在心力衰竭护理中的有针对性和成本效益应用的证据.
- 研究结果将为国家和国际医院制定有效的远程医疗战略提供信息.
- 这项研究有助于优化慢性疾病管理的数字健康解决方案.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
433
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
433
01:22Heart Failure Drugs: β-Blockers
341
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
341
01:22Heart Failure Drugs: Diuretics
388
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
388
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:26Heart Failure Drugs: Inotropic Agents
591
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
591